Cart
sales@molnova.com
Imiloxan
CAS No. 81167-16-0
Imiloxan( —— )
Catalog No. M34283 CAS No. 81167-16-0
Imiloxan (RS-21361) is an α2 adrenergic receptor antagonist used in the treatment of major depressive disorder.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 560 | In Stock |
|
| 10MG | 757 | In Stock |
|
| 25MG | 1121 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameImiloxan
-
NoteResearch use only, not for human use.
-
Brief DescriptionImiloxan (RS-21361) is an α2 adrenergic receptor antagonist used in the treatment of major depressive disorder.
-
DescriptionImiloxan is a potent and selective alpha 2B-adrenoceptor antagonist. Imiloxan has the potential for acute kidney injury research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdrenergic Receptor
-
RecptorAdrenergic Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number81167-16-0
-
Formula Weight244.29
-
Molecular FormulaC14H16N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=1C=CN(C1CC2OC=3C=CC=CC3OC2)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. A D Michel, et al. Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. Br J Pharmacol. 1990 Mar;99(3):560-4. ?
molnova catalog
related products
-
Soquinolol
Soquinolol (Soquinolol mucate) is a beta-adrenergic receptor antagonist with weak local anesthetic activity.Soquinolol has good enteral efficacy and a long duration of action.
-
Nemazoline Free Base
Nemazoline Free Base acts as an α1-adrenergic agonist and an α2-adrenergic antagonist, and may be used in the treatment of trace amine-associated receptor-related disorders.
-
5-Bromoimidazo[1,2-A...
5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
